2 results match your criteria: "Breast Oncology Program Taussig Cancer Institute Cleveland Clinic Cleveland[Affiliation]"
Introduction and commentary: Paving the way for biosimilars in oncology, part 3: Clinical and economic impact of oncology biosimilars.
Semin Oncol
April 2014
Director, Breast Oncology Program Taussig Cancer Institute Cleveland Clinic Cleveland, OH. Electronic address:
Introduction and commentary: paving the way for biosimilars in oncology, part 2: focus on safety and clinical trial considerations.
Semin Oncol
February 2014
Director, Breast Oncology Program Taussig Cancer Institute Cleveland Clinic Cleveland, OH. Electronic address: